拉帕替尼联合微波热疗治疗HER2阳性晚期乳腺癌的疗效OA
Efficacy of lapatinib combined with microwave hyperthermia in the treatment of HER2-positive advanced breast cancer
目的 研究拉帕替尼联合微波热疗治疗人类表皮生长因子受体 2(human epidermal growth factor receptor 2,HER2)阳性晚期乳腺癌患者的疗效.方法 选取 2019 年 1 月至 2020 年 1 月于湖州市中心医院就诊的HER2 阳性晚期乳腺癌患者 134 例,根据抽签法将其分为对照组和观察组,每组各 67 例.两组均使用拉帕替尼治疗,观察组患者在此基础上联合微波热疗治疗.比较两组患者治疗前后的肿瘤标志物[糖类…查看全部>>
Objective To investigate the efficacy of lapatinib combined with microwave hyperthermia in the treatment of human epidermal growth factor receptor 2(HER2)positive advanced breast cancer.Methods A total of 134 patients with HER2-positive advanced breast cancer treated in Huzhou Central Hospital from January 2019 to January 2020 were selected and divided into control group and observation group according to the lottery method,with 67 cases in each group.Both g…查看全部>>
朱月丰;宋建文;戴妍妍
湖州市中心医院乳腺外科,浙江湖州 313000湖州市中心医院乳腺外科,浙江湖州 313000湖州市中心医院乳腺外科,浙江湖州 313000
临床医学
拉帕替尼微波热疗人类表皮生长因子受体2晚期乳腺癌波形蛋白生存期
LapatinibMicrowave hyperthermiaHuman epidermal growth factor receptor 2Advanced breast cancerVimentinSurvival time
《中国现代医生》 2024 (16)
4-8,5
浙江省科技计划项目(2018C37089)
评论